Interest of Pulsatile Perfusion Preservation on Outcomes in Kidney Transplantation From Expanded Criteria Donors
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 162
- 试验地点
- 2
- 主要终点
- Delayed graft function (DGF) rate defined as the need to resort to dialysis during the first week after transplantation. The main dialysis factors retained are hydrosodic and/or hyperkalemic overload.
研究概览
简要总结
Our hypothesis is that the Waters Medical® pulsatile perfusion machine (RM 3) is a way to improve delayed graft function (DGF) in marginal grafts, and some perfusion profiles (flow, pressure, resistance index, venous effluent pH) are correlated with better recovery of renal function (without dialysis during the first week after transplant).
Observation or Investigation Method Used :
The study is multicenter, prospective, open, controlled and randomized:grafts are divided into two parallel groups:
- group 1 corresponds to a conservation of grafts in static incubation
- group 2 corresponds to conservation using a pulsatile perfusion machine
Duration and Organizational Arrangements for Research :
The total duration of the study is planned for 36 months. This duration includes:
- an inclusion period that will last 24 months,
- the follow-up of recipient patients from the day of transplantation until twelve months after the operation
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Delayed graft function (DGF) rate defined as the need to resort to dialysis during the first week after transplantation. The main dialysis factors retained are hydrosodic and/or hyperkalemic overload.
时间窗: First week after transplantation
次要结局
- Evaluate improvement in the glomerular filtering rate(12 months after transplantation)
- Evaluate the recourse to dialysis(3 months following transplantation)
- Evaluate the proportion of functional grafts (which allows for renal purification without recourse to dialysis)(12 months after transplantation)
- Evaluate patient survival(12 months after transplantation)
- Stratify the analysis of regaining function and graft survival using Nyberg's classification in order to determine which risk groups would most benefit from pulsatile perfusion.(12 months after transplantation)
- Evaluate the medico-economic impact of each conservation strategy in the management of patients who will benefit from marginal grafts(12 months after transplantation)
- Identify perfusion profiles of the machine, which predict regaining renal function (absence of dialysis during the week after transplantation) and graft survival(12 months after transplantation)